Lithium use for the treatment of mood disorders remains quite low, particularly in the United
States compared with some European countries. Mogens Schou pioneered the study of …

Outpatient clinicians treating OABD should take an active role in the recognition and
management of medical comorbidities. A careful history and examination might reveal subtle …

Background Lithium is well recognized as the first-line maintenance treatment for bipolar
disorder (BD). However, besides therapeutic benefits attributed to lithium therapy, the …

Background Lithium is the most effective treatment in bipolar disorder. Its use is limited by
concerns about risk of chronic kidney disease (CKD). We aimed to develop a model to …

Objectives Clinical practice guidelines (CPG s) for treatment of bipolar disorder (BD) aim to
provide guidance to health care professionals on monitoring of patients using lithium. The …

Background Lithium in the form of lithium carbonate (Li 2 CO 3) has become one of the most
effective and widely prescribed drugs for mood stabilization. However, lithium has adverse …

Leaching experiments were performed on zinnwaldite-rich greisen, pure zinnwaldite
separated from the greisen, spodumene pegmatite, and pure lepidolite in dilute sulfuric …

Background Numerous drugs have been associated with urinary retention (UR), but updated
information on drugs that may induce UR is limited. Objective To evaluate drug-induced UR …

Background: Little is known of the risks involved for patients who, at the start of lithium
treatment, already have compromised renal function. Aims: To assess the risk of developing …

Background: This study compared the largest set of bipolar disorder pharmacotherapies to
date (71 drugs and drug combinations) for risk of kidney disorders (KDs). Methods: This …